1.The Efficacy and Safety of a Human Perirenal Adipose TissueDerived Stromal Vascular Fraction in an Interstitial Cystitis Rat Model
Ji Yong HA ; Eun Hye LEE ; So Young CHUN ; Jun Nyung LEE ; Yun-Sok HA ; Jae-Wook CHUNG ; Bo Hyun YOON ; Minji JEON ; Hyun Tae KIM ; Tae Gyun KWON ; Eun Sang YOO ; Bum Soo KIM
Tissue Engineering and Regenerative Medicine 2023;20(2):225-237
BACKGROUND:
Interstitial cystitis (IC) is a chronic and intractable disease that can severely deteriorate patients’ quality of life. Recently, stem cell therapy has been introduced as a promising alternative treatment for IC in animal models. We aimed to verify the efficacy and safety of the human perirenal adipose tissue-derived stromal vascular fraction (SVF) in an IC rat model.
METHODS:
From eight-week-old female rats, an IC rat model was established by subcutaneous injection of 200 lg of uroplakin3A. The SVF was injected into the bladder submucosal layer of IC rats, and pain scale analysis, awakening cytometry, and histological and gene analyses of the bladder were performed. For the in vivo safety analysis, genomic DNA purification and histological analysis were also performed to check tumorigenicity and thrombus formation.
RESULTS:
The mean pain scores in the SVF 20 ll group were significantly lower on days 7 and 14 than those in the control group, and bladder intercontraction intervals were significantly improved in the SVF groups in a dose-dependent manner. Regeneration of the bladder epithelium, basement membrane, and lamina propria was observed in the SVF group.In the SVF groups, however, bladder fibrosis and the expression of inflammatory markers were not significantly improved compared to those in the control group.
CONCLUSION
This study demonstrated that a perirenal adipose tissue-derived SVF is a promising alternative for the management of IC in terms of improving bladder pain and overactivity.
2.In Vivo Safety and Regeneration of Long-Term Transported Amniotic Fluid Stem Cells for Renal Regeneration
Na hee YU ; So Young CHUN ; Yun Sok HA ; Hyun Tae KIM ; Eugene LIH ; Dae Hwan KIM ; Jeongshik KIM ; Jae Wook CHUNG ; Phil Hyun SONG ; Eun Sang YOO ; Sung Kwang CHUNG ; Dong Keun HAN ; Bum Soo KIM ; Tae Gyun KWON
Tissue Engineering and Regenerative Medicine 2019;16(1):81-92
BACKGROUND: Despite major progress in stem cell therapy, our knowledge of the characteristics and tissue regeneration potency of long-term transported cells is insufficient. In a previous in vitro study, we established the optimal cell transport conditions for amniotic fluid stem cells (AFSCs). In the present study, the target tissue regeneration of long-term transported cells was validated in vivo. METHODS: For renal regeneration, transported AFSCs were seeded on a poly(lactide-co-glycolide) scaffold and implanted in a partially resected kidney. The target tissue regeneration of the transported cells was compared with that of freshly harvested cells in terms of morphological reconstruction, histological microstructure reformation, immune cell infiltration, presence of induced cells, migration into remote organs, expression of inflammation/fibrosis/renal differentiation-related factors, and functional recovery. RESULTS: The kidney implanted with transported cells showed recovery of total kidney volume, regeneration of glomerular/renal tubules, low CD4/CD8 infiltration, and no occurrence of cancer during 40 weeks of observation. The AFSCs gradually disappeared and did not migrate into the liver, lung, or spleen. We observed low expression levels of proinflammatory cytokines and fibrotic factors; enhanced expression of the genes Wnt4, Pax2, Wt1, and Emx2; and significantly reduced blood urea nitrogen and creatinine values. There were no statistical differences between the performance of freshly harvested cells and that of the transported cells. CONCLUSION: This study demonstrates that long-term transported cells under optimized conditions can be used for cell therapy without adverse effects on stem cell characteristics, in vivo safety, and tissue regeneration potency.
Amniotic Fluid
;
Blood Urea Nitrogen
;
Cell- and Tissue-Based Therapy
;
Creatinine
;
Cytokines
;
Female
;
In Vitro Techniques
;
Kidney
;
Liver
;
Lung
;
Polyglactin 910
;
Regeneration
;
Spleen
;
Stem Cells
3.Medical Travel among Non-Seoul Residents to Seek Prostate Cancer Treatment in Medical Facilities of Seoul.
Jae Heon KIM ; So Young KIM ; Seok Joong YUN ; Jae Il CHUNG ; Hoon CHOI ; Ho Song YU ; Yun Sok HA ; In Chang CHO ; Hyung Joon KIM ; Hyun Chul CHUNG ; Jun Sung KOH ; Wun Jae KIM ; Jong Hyock PARK ; Ji Youl LEE
Cancer Research and Treatment 2019;51(1):53-64
PURPOSE: This study aims to investigate the trend in medical travel by non-Seoul residents to Seoul for treatment of prostate cancer and also to investigate the possible factors affecting the trend. MATERIALS AND METHODS: This study represents a retrospective cohort study using data from theKoreanNationalHealth Insurance System from 2002 to 2015. Annual trends were produced for proportions of patients who traveled according to the age group, economic status and types of treatment. Multiple logistic analysiswas used to determine factors affecting surgeries at medical facilities in Seoul among the non-Seoul residents. RESULTS: A total of 68,543 patients were defined as newly diagnosed prostate cancer cohorts from 2005 to 2014. The proportion of patients who traveled to Seoul for treatment, estimated from cases with prostate cancer-related claims, decreased slightly over 9 years (28.0 at 2005 and 27.0 at 2014, p=0.02). The average proportion of medical travelers seeking radical prostatectomy increased slightly but the increase was not statistically significant (43.1 at 2005 and 45.4 at 2014, p=0.26). Income level and performance ofrobot-assisted radical prostatectomy were significant positive factors for medical travel to medical facilities in Seoul. Combined comorbidity diseases and year undergoing surgery were significant negative factors for medical travel to medical facilities in Seoul. CONCLUSION: The general trend of patients travelling from outside Seoul for prostate cancer treatment decreased from 2005 to 2014. However, a large proportion of traveling remained irrespective of direct distance from Seoul.
Cohort Studies
;
Comorbidity
;
Geography
;
Health Services Accessibility
;
Humans
;
Insurance
;
Prostate*
;
Prostatectomy
;
Prostatic Neoplasms*
;
Retrospective Studies
;
Seoul*
4.Susceptibility of the Index Urinary Tract Infection to Prophylactic Antibiotics Is a Predictive Factor of Breakthrough Urinary Tract Infection in Children with Primary Vesicoureteral Reflux Receiving Continuous Antibiotic Prophylaxis
Jun Nyung LEE ; Kyeong Hyeon BYEON ; Myeong Jin WOO ; Hee Sun BAEK ; Min Hyun CHO ; Shin Young JEONG ; So Mi LEE ; Ji Yeon HAM ; Yun Sok HA ; Hyun Tae KIM ; Eun Sang YOO ; Tae Gyun KWON ; Sung Kwang CHUNG
Journal of Korean Medical Science 2019;34(21):e156-
BACKGROUND: Few studies have reported on breakthrough urinary tract infection (UTI) associated with the susceptibility of index UTI to prophylactic antibiotics in children with primary vesicoureteral reflux (VUR) receiving continuous antibiotic prophylaxis (CAP). We assessed the impact of the susceptibility of index UTI to prophylactic antibiotics in breakthrough UTIs in children with primary VUR receiving CAP. METHODS: We retrospectively reviewed the medical records of 81 children with primary VUR who were diagnosed after febrile or symptomatic UTI and subsequently received trimethoprim-sulfamethoxazole (TMP-SMX) as CAP between January 2010 and December 2013. We allocated children to a susceptible group or a resistant group based on the susceptibility of index UTI to TMP-SMX. We evaluated patient demographics and clinical outcomes after CAP according to the susceptibility of index UTI to TMP-SMX. Multivariate analysis was used to identify the predictive factors for breakthrough UTI. RESULTS: Of the 81 children, 42 were classified into the susceptible group and 39 into the resistant group. The proportion of breakthrough UTI was 31.0% (13/42) in the susceptible group and 53.8% (21/39) in the resistant group (P = 0.037). Progression of renal scarring was observed in 0% of children in the susceptible group and 15% in the resistant group (P = 0.053). Multivariate analysis showed that TMP-SMX resistance and initial renal scarring were significant predictors of breakthrough UTI. CONCLUSION: Susceptibility of index UTI to prophylactic antibiotics is a risk factor of breakthrough UTI and is associated with poor clinical outcomes in children with primary VUR receiving CAP.
Anti-Bacterial Agents
;
Antibiotic Prophylaxis
;
Child
;
Cicatrix
;
Demography
;
Humans
;
Medical Records
;
Multivariate Analysis
;
Retrospective Studies
;
Risk Factors
;
Trimethoprim, Sulfamethoxazole Drug Combination
;
Urinary Tract Infections
;
Urinary Tract
;
Vesico-Ureteral Reflux
5.A Novel Dorsal Slit Approached Non-Ischemic Partial Nephrectomy Method for a Renal Tissue Regeneration in a Mouse Model.
So Young CHUN ; Dae Hwan KIM ; Jeong Shik KIM ; Hyun Tae KIM ; Eun Sang YOO ; Jae Wook CHUNG ; Yun Sok HA ; Phil Hyun SONG ; Yoon Ki JOUNG ; Dong Keun HAN ; Sung Kwang CHUNG ; Bum Soo KIM ; Tae Gyun KWON
Tissue Engineering and Regenerative Medicine 2018;15(4):453-466
BACKGROUND: Kidney ischemia-reperfusion (IR) via laparotomy is a conventional method for kidney surgery in a mouse model. However, IR, an invasive procedure, can cause serious acute and chronic complications through apoptotic and inflammatory pathways. To avoid these adverse responses, a Non-IR and dorsal slit approach was designed for kidney surgery. METHODS: Animals were divided into three groups, 1) sham-operated control; 2) IR, Kidney IR via laparotomy; and 3) Non-IR, Non-IR and dorsal slit. The effects of Non-IR method on renal surgery outcomes were verified with respect to animal viability, renal function, apoptosis, inflammation, fibrosis, renal regeneration, and systemic response using histology, immunohistochemistry, real-time polymerase chain reaction, serum chemistry, terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining, and Masson's trichrome staining. RESULTS: The Non-IR group showed 100% viability with mild elevation of serum blood urea nitrogen and creatinine values at day 1 after surgery, whereas the IR group showed 20% viability and lethal functional abnormality. Histologically, renal tubule epithelial cell injury was evident on day 1 in the IR group, and cellular apoptosis enhanced TUNEL-positive cell number and Fas/caspase-3 and KIM-1/NGAL expression. Inflammation and fibrosis were high in the IR group, with enhanced CD4/CD8-positive T cell infiltration, inflammatory cytokine secretion, and Masson's trichrome stain-positive cell numbers. The Non-IR group showed a suitable microenvironment for renal regeneration with enhanced host cell migration, reduced immune cell influx, and increased expression of renal differentiation-related genes and anti-inflammatory cytokines. The local renal IR influenced distal organ apoptosis and inflammation by releasing circulating pro-inflammatory cytokines. CONCLUSION: The Non-IR and dorsal slit method for kidney surgery in a mouse model can be an alternative surgical approach for researchers without adverse reactions such as apoptosis, inflammation, fibrosis, functional impairment, and systemic reactions.
Animals
;
Apoptosis
;
Blood Urea Nitrogen
;
Cell Count
;
Cell Movement
;
Chemistry
;
Creatinine
;
Cytokines
;
DNA Nucleotidylexotransferase
;
Epithelial Cells
;
Fibrosis
;
Immunohistochemistry
;
Inflammation
;
Kidney
;
Laparotomy
;
Methods*
;
Mice*
;
Nephrectomy*
;
Real-Time Polymerase Chain Reaction
;
Regeneration*
6.In Vivo Validation Model of a Novel Anti-Inflammatory Scaffold in Interleukin-10 Knockout Mouse.
Jung Yeon KIM ; So Young CHUN ; Sang Hoon LEE ; Eugene LIH ; Jeongshik KIM ; Dae Hwan KIM ; Yun Sok HA ; Jae Wook CHUNG ; Jun Nyung LEE ; Bum Soo KIM ; Hyun Tae KIM ; Eun Sang YOO ; Dong Keun HAN ; Tae Gyun KWON ; Byung Ik JANG
Tissue Engineering and Regenerative Medicine 2018;15(4):381-392
BACKGROUND: We fabricated anti-inflammatory scaffold using Mg(OH)2-incorporated polylactic acid-polyglycolic acid copolymer (MH-PLGA). To demonstrate the anti-inflammatory effects of the MH-PLGA scaffold, an animal model should be sensitive to inflammatory responses. The interleukin-10 knockout (IL-10 KO) mouse is a widely used bowel disease model for evaluating inflammatory responses, however, few studies have evaluated this mouse for the anti-inflammatory scaffold. METHODS: To compare the sensitivity of the inflammatory reaction, the PLGA scaffold was implanted into IL-10 KO and C57BL/6 mouse kidneys. Morphology, histology, immunohistochemistry, and gene expression analyses were carried out at weeks 1, 4, 8, and 12. The anti-inflammatory effect and renal regeneration potency of the MH-PLGA scaffold was also compared to those of PLGA in IL-10 KO mice. RESULTS: The PLGA scaffold-implanted IL-10 KO mice showed kidneys relatively shrunken by fibrosis, significantly increased inflammatory cell infiltration, high levels of acidic debris residue, more frequent CD8-, C-reactive protein-, and ectodysplasin A-positive cells, and higher expression of pro-inflammatory and fibrotic factors compared to the control group. The MH-PLGA scaffold group showed lower expression of pro-inflammatory and fibrotic factors, low immune cell infiltration, and significantly higher expression of anti-inflammatory factors and renal differentiation related genes compared to the PLGA scaffold group. CONCLUSION: These results indicate that the MH-PLGA scaffold had anti-inflammatory effects and high renal regeneration potency. Therefore, IL-10 KO mice are a suitable animal model for in vivo validation of novel anti-inflammatory scaffolds.
Animals
;
Ectodysplasins
;
Fibrosis
;
Gene Expression
;
Immunohistochemistry
;
Interleukin-10*
;
Kidney
;
Mice
;
Mice, Knockout*
;
Models, Animal
;
Regeneration
7.Optimal Stem Cell Transporting Conditions to Maintain Cell Viability and Characteristics.
Na Hee YU ; So Young CHUN ; Yun Sok HA ; Hyun Tae KIM ; Dae Hwan KIM ; Jeongshik KIM ; Jae Wook CHUNG ; Jun Nyung LEE ; Phil Hyun SONG ; Eun Sang YOO ; Bum Soo KIM ; Tae Gyun KWON
Tissue Engineering and Regenerative Medicine 2018;15(5):639-647
BACKGROUND: The preservation of stem cell viability and characteristics during cell transport from the bench to patients can significantly affect the success of cell therapy. Factors such as suspending medium, time, temperature, cell density, and container type could be considered for transport conditions. METHODS: To establish optimal conditions, human amniotic fluid stem cells' (AFSCs) viabilities were analyzed under different media {DMEM(H), DMEM/F-12, K-SFM, RPMI 1640, α-MEM, DMEM(L), PBS or saline}, temperature (4, 22 or 37 ℃), cell density (1 × 10⁷ cells were suspended in 0.1, 0.5, 1.0 or 2.0 mL of medium) and container type (plastic syringe or glass bottle). After establishing the transport conditions, stem cell characteristics of AFSCs were compared to freshly prepared cells. RESULTS: Cells transported in DMEM(H) showed relatively higher viability than other media. The optimized transport temperature was 4 ℃, and available transport time was within 12 h. A lower cell density was associated with a better survival rate, and a syringe was selected as a transport container because of its clinical convenience. In compare of stem cell characteristics, the transported cells with established conditions showed similar potency as the freshly prepared cells. CONCLUSION: Our findings can provide a foundation to optimization of conditions for stem cell transport.
Amniotic Fluid
;
Cell Count
;
Cell Survival*
;
Cell- and Tissue-Based Therapy
;
Female
;
Glass
;
Humans
;
Stem Cells*
;
Survival Rate
;
Syringes
8.Oncological and functional outcomes following robot-assisted laparoscopic radical prostatectomy at a single institution: a minimum 5-year follow-up
Jun Koo KANG ; Jae Wook CHUNG ; So Young CHUN ; Yun Sok HA ; Seock Hwan CHOI ; Jun Nyung LEE ; Bum Soo KIM ; Ghil Suk YOON ; Hyun Tae KIM ; Tae Hwan KIM ; Tae Gyun KWON
Yeungnam University Journal of Medicine 2018;35(2):171-178
BACKGROUND: To evaluate mid-term oncological and functional outcomes in patients with prostate cancer treated by robot-assisted laparoscopic radical prostatectomy (RALP) at our institution.METHODS: We retrospectively reviewed the medical records of 128 patients with prostate cancer who underwent RALP at our institution between February 2008 and April 2010. All patients enrolled in this study were followed up for at least 5 years. We analyzed biochemical recurrence (BCR)-free survival using a Kaplan-Meier survival curve analysis and predictive factors for BCR using multivariate Cox regression analysis. Continence recovery rate, defined as no use of urinary pads, was also evaluated.RESULTS: Based on the D'Amico risk classification, there were 30 low-risk patients (23.4%), 47 intermediate-risk patients (38.8%), and 51 high-risk patients (39.8%), preoperatively. Based on pathological findings, 50.0% of patients (64/128) showed non-organ confined disease (≥T3a) and 26.6% (34/128) had high grade disease (Gleason score ≥8). During a median follow-up period of 71 months (range, 66–78 months), the frequency of BCR was 33.6% (43/128) and the median BCR-free survival was 65.9 (0.4–88.0) months. Multivariate Cox regression analysis revealed that high grade disease (Gleason score ≥8) was an independent predictor for BCR (hazard ratio=4.180, 95% confidence interval=1.02–17.12, p=0.047). In addition, a majority of patients remained continent following the RALP procedure, without the need for additional intervention for post-prostatectomy incontinence.CONCLUSION: Our study demonstrated acceptable outcomes following an initial RALP procedure, despite 50% of the patients investigated demonstrating high-risk features associated with non-organ confined disease.
Classification
;
Follow-Up Studies
;
Humans
;
Medical Records
;
Prostatectomy
;
Prostatic Neoplasms
;
Recurrence
;
Retrospective Studies
;
Urinary Incontinence
9.Oncological and functional outcomes following robot-assisted laparoscopic radical prostatectomy at a single institution: a minimum 5-year follow-up
Jun Koo KANG ; Jae Wook CHUNG ; So Young CHUN ; Yun Sok HA ; Seock Hwan CHOI ; Jun Nyung LEE ; Bum Soo KIM ; Ghil Suk YOON ; Hyun Tae KIM ; Tae Hwan KIM ; Tae Gyun KWON
Yeungnam University Journal of Medicine 2018;35(2):171-178
BACKGROUND:
To evaluate mid-term oncological and functional outcomes in patients with prostate cancer treated by robot-assisted laparoscopic radical prostatectomy (RALP) at our institution.
METHODS:
We retrospectively reviewed the medical records of 128 patients with prostate cancer who underwent RALP at our institution between February 2008 and April 2010. All patients enrolled in this study were followed up for at least 5 years. We analyzed biochemical recurrence (BCR)-free survival using a Kaplan-Meier survival curve analysis and predictive factors for BCR using multivariate Cox regression analysis. Continence recovery rate, defined as no use of urinary pads, was also evaluated.
RESULTS:
Based on the D'Amico risk classification, there were 30 low-risk patients (23.4%), 47 intermediate-risk patients (38.8%), and 51 high-risk patients (39.8%), preoperatively. Based on pathological findings, 50.0% of patients (64/128) showed non-organ confined disease (≥T3a) and 26.6% (34/128) had high grade disease (Gleason score ≥8). During a median follow-up period of 71 months (range, 66–78 months), the frequency of BCR was 33.6% (43/128) and the median BCR-free survival was 65.9 (0.4–88.0) months. Multivariate Cox regression analysis revealed that high grade disease (Gleason score ≥8) was an independent predictor for BCR (hazard ratio=4.180, 95% confidence interval=1.02–17.12, p=0.047). In addition, a majority of patients remained continent following the RALP procedure, without the need for additional intervention for post-prostatectomy incontinence.
CONCLUSION
Our study demonstrated acceptable outcomes following an initial RALP procedure, despite 50% of the patients investigated demonstrating high-risk features associated with non-organ confined disease.
10.Comparison of 5 Different Rat Models to Establish a Standard Animal Model for Research Into Interstitial Cystitis.
Phil Hyun SONG ; So Young CHUN ; Jae Wook CHUNG ; Yeon Yong KIM ; Hyo Jung LEE ; Jun Nyung LEE ; Yun Sok HA ; Eun Sang YOO ; Tae Gyun KWON ; Jeongshik KIM ; Dae Hwan KIM ; Bum Soo KIM
International Neurourology Journal 2017;21(3):163-170
PURPOSE: We evaluated 5 different rat models using different agents in order to establish a standard animal model for interstitial cystitis (IC) in terms of the functional and pathologic characteristics of the bladder. METHODS: Five IC models were generated in 8-week-old female Sprague-Dawley rats via transurethral instillation of 0.1M hydrogen chloride (HCl) or 3% acetic acid (AA), intraperitoneal injection of cyclophosphamide (CYP) or lipopolysaccharide (LPS), or subcutaneous injection of uroplakin II (UPK2). After generating the IC models, conscious cystometry was performed on days 3, 7, and 14. All rats were euthanized on day 14 and their bladders were obtained for histological and pro-inflammatory-related gene expression analysis. RESULTS: In the cystometric analysis, all experimental groups showed significantly decreased intercontraction intervals compared with the control group on day 3, but only the LPS and UPK groups maintained significantly shorter intercontraction intervals than the control group on day 14. The histological analysis revealed that areas with severe urothelial erosion (HCl, AA, and UPK) and hyperplasia (CYP and LPS), particularly in the UPK-treated bladders, showed a markedly increased infiltration of toluidine blue-stained mast cells and increased tissue fibrosis. In addition, significantly elevated expression of interleukin-1b, interleukin-6, myeloperoxidase, monocyte chemotactic protein 1, and Toll-like receptors 2 and 4 was observed in the UPK group compared to the other groups. CONCLUSIONS: Among the 5 different agents, the injection of UPK generated the most effective IC animal model, showing consequent urothelial barrier loss, inflammatory reaction, tissue fibrosis stimulation, and persistent hyperactive bladder.
Acetic Acid
;
Animals
;
Animals*
;
Chemokine CCL2
;
Cyclophosphamide
;
Cystitis, Interstitial*
;
Female
;
Fibrosis
;
Gene Expression
;
Humans
;
Hydrochloric Acid
;
Hyperplasia
;
Immunization
;
Injections, Intraperitoneal
;
Injections, Subcutaneous
;
Interleukin-6
;
Mast Cells
;
Models, Animal*
;
Peroxidase
;
Rats*
;
Rats, Sprague-Dawley
;
Toll-Like Receptors
;
Urinary Bladder
;
Uroplakin II

Result Analysis
Print
Save
E-mail